ResearcherInsermNo recent work listed

Clémence Canton

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4720-4110; OpenAlex author ID A5000820846. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1093/oncolo/oyac055 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Laëtitia Dahan · 1 shared paper, 2022 · strength 0.16
- Paper Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with M… DOI 10.1093/oncolo/oyac055 ↗
Côme Lepage · 1 shared paper, 2022 · strength 0.16
- Paper Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with M… DOI 10.1093/oncolo/oyac055 ↗
Julien Taı̈eb · 1 shared paper, 2022 · strength 0.16
- Paper Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with M… DOI 10.1093/oncolo/oyac055 ↗
Jean‐Baptiste Bachet · 1 shared paper, 2022 · strength 0.16
- Paper Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with M… DOI 10.1093/oncolo/oyac055 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.